Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH
84 search results for:

Acute myeloid leukemia 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 24-10-2017 | Acute myeloid leukemia | Article

    Measurement of residual disease in acute myeloid leukemia

    Vedula RS & Lindsley RC. Curr Hematol Malig Rep  2017. doi:10.1007/s11899-017-0428-4

  2. 25-07-2017 | Acute myeloid leukemia | Article

    Recent developments in immunotherapy of acute myeloid leukemia

    This review surveys the current most prominent concepts in the immunotherapy of acute myeloid leukemia as well as the considerable progress made over the past few years. Lichtenegger FS et al. J Hematol Oncol 2017; 10: 142. doi:10.1186/s13045-017-0505-0

  3. 18-12-2017 | Acute myeloid leukemia | Article

    Chromothripsis in acute myeloid leukemia: Biological features and impact on survival

    Fontana M et al.  Leukemia 2017; doi:10.1038/leu.2017.351

  4. 13-10-2017 | Acute myeloid leukemia | Article

    The prognostic significance of measurable (“minimal”) residual disease in acute myeloid leukemia

    In this review, Buccisano et al evaluate recent literature on detection methodologies for, and prognostic significance of, measurable residual disease in acute myeloid leukemia. Buccisano F, Hourigan CS & Walter RB Curr Hematol Malig Rep 2017. doi:10.1007/s11899-017-0420-z

  5. 15-11-2016 | Hematologic cancers | Book chapter | Article

    Therapeutic management of acute myeloid leukemia

    In this chapter Fiegl provides an overview of the treatment options for patients with acute myeloid leukemia by phase, with resistant/relapsed disease, and in those deemed medically unfit and elderly. In: Handbook f Acute Leukemia . Edited by Hiddemann W. Springer International Publishing, 2016. doi:10.1007/978-3-319-26772-2_5

    Author:
    Michael Fiegl
  6. 08-11-2017 | Leukemia | Article

    Asparaginase Erwinia chrysanthemi effectively depletes plasma glutamine in adult patients with relapsed/refractory acute myeloid leukemia

    Emadi A, Law JY, Strovel ET et al. Cancer Chemother Pharmacol 2018; 81(1):217  doi:10.1007/s00280-017-3459-6

  7. 18-12-2017 | Acute myeloid leukemia | Article

    Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia

    Rothenberg-Thurley M et al. Leukemia 2017; doi:10.1038/leu.2017.350

  8. 24-10-2017 | Acute myeloid leukemia | Article

    Diagnostic and prognostic utility of fluorescence in situ hybridization (FISH) analysis in acute myeloid leukemia

    The authors review the use of several fluorescence in situ hybridization probe strategies in the diagnosis of acute myeloid leukemia (AML), together with current clinical guidelines for AML diagnosis. Gonzales PR & Mikhail FM. Curr Hematol Malig Rep 2017. doi:10.1007/s11899-017-0426-6

  9. 23-11-2017 | Leukemia | Article

    Levofloxacin for febrile neutropenia prophylaxis in acute myeloid leukemia patients associated with reduction in hospital admissions

    Lee SSF, Fulford AE, Quinn MA, Seabrook J & Rajakumar I. Support Care Cancer 2017. doi:10.1007/s00520-017-3976-1

  10. 11-12-2017 | Acute myeloid leukemia | Article

    The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions

    Bolouri H et al. Nat Med  2017; doi:10.1038/nm.4439

  11. 31-10-2017 | Acute myeloid leukemia | Article

    The role of mutant IDH1 and IDH2 inhibitors in the treatment of acute myeloid leukemia

    This article summarizes the role of isocitrate dehydrogenase (IDH)-1 and IDH2 mutations in leukemogenesis, and covers recent clinical trials evaluating the effect of direct inhibition of IDH1 and IDH2. Nassereddine S, Lap CJ, Haroun F et al. Ann Hematol 2017; 96:1983. doi:10.1007/s00277-017-3161-0

  12. 12-01-2018 | Acute myeloid leukemia | Article

    Impact of antithymocyte globulin doses in reduced intensity conditioning before allogeneic transplantation from matched sibling donor for patients with acute myeloid leukemia: a report from the acute leukemia working party of European group of Bone Marrow Transplantation

    Devillier R et al. Bone Marrow Transplant  2018; doi:10.1038/s41409-017-0043-y

  13. 27-02-2018 | Leukemia | Article

    Universal genetic testing for inherited susceptibility in children and adults with myelodysplastic syndrome and acute myeloid leukemia: are we there yet?

    Tawana K et al. Leukemia  2018. doi:10.1038/s41375-018-0051-y

  14. 27-02-2018 | Acute myeloid leukemia | Article

    Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012

    Rasche M et al. Leukemia 2018. doi:10.1038/s41375-018-0071-7

  15. 31-10-2017 | Acute myeloid leukemia | Article

    Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO)

    Nagel G, Weber D, Fromm E et al. Ann Hematol 2017; 96:1993. doi:10.1007/s00277-017-3150-3

  16. 10-01-2018 | Acute myeloid leukemia | Article

    Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1

    Saygin C et al. Blood Cancer J 2018; doi:10.1038/s41408-017-0040-9

  17. 14-03-2017 | Leukemia | Editorial | Article

    FMS-like tyrosine kinase 3 (FLT3)-inhibition in FLT3 mutated acute myeloid leukemia: A promising approach

    Advisory Board Member Xavier Thomas discusses the potential of FLT3 inhibitors for the treatment of acute myeloid leukemia.

    Author:
    Xavier Thomas MD
  18. 12-12-2016 | Pediatric leukemia | Article

    Cytogenetics and outcome of allogeneic transplantation in first remission of acute myeloid leukemia: the French pediatric experience

    Cytogenetic analysis has become a useful tool in the prediction of survival and adaptation of acute myeloid leukemia therapy. Using data from two French studies, Alloin et al. measure the impact of cytogenetic risk stratification. Alloin A-L et al. Bone Marrow Transplant  2017; 52: 516–521. doi:10.1038/bmt.2016.293

  19. 27-11-2017 | Leukemia | Article

    Minimal residual disease by either flow cytometry or cytogenetics prior to an allogeneic hematopoietic stem cell transplant is associated with poor outcome in acute myeloid leukemia

    Blood Cancer J 2017; 7(12)634. doi:10.1038/s41408-017-0007-x

    Author:
    Maxim Norkin, Lakshmikanth Katragadda, Fei Zou, Sican Xiong, Myron Chang, Yunfeng Dai, Jack W. Hsu, Jan S. Moreb, Helen Leather, Hemant S. Murthy, Nosha Farhadfar, Ying Li, Robert Hromas, Randy A. Brown, Christopher R. Cogle, John R. Wingard
  20. 05-05-2023 | Breast cancer | News | Article

    DESTINY-Breast02 supports T-DXd as ‘preferred’ regimen after progression on T-DM1

    And there were four fatal drug-related TEAEs in the T-DXd group – two cases of pneumonitis and one each of acute myeloid leukemia and pneumonia – versus none in the control group.

    Author:
    Shreeya Nanda
    Published in:
    Lancet 2023; doi:10.1016/S0140-6736(23)00620-7 Lancet 2023; doi:10.1016/S0140-6736(23)00732-8

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.